Previous Immune Checkpoint Inhibitor Therapy is Associated with Decreased COVID-19-related Hospitalizations and Complications in Patients with Cancer: Results of a Propensity-Matched Analysis of the OnCovid Registry Anahita Mostaghim , Samuel Minkove , Juan Aguilar-Company , Isabel Ruiz-Camps , Simeon Eremiev-Eremiev , Gino M. Dettorre , Laura Fox , Carlo Tondini , Joan Brunet , Mcarmen Carmona-Garcia , Matteo Lambertini , Mark Bower , Thomas Newsom-Davis , Rachel Sharkey , Alessia Dalla Pria , Maura Rossi , Andrea Plaja , Ramon Salazar , Anna Sureda , Aleix Prat , Vasiliki Michalarea , Mieke Van Hemelrijck , Ailsa Sita-Lumsden , Alexia Bertuzzi , Lorenza Rimassa , Sabrina Rossi , Gianpiero Rizzo , Paolo Pedrazzoli , Alvin Jx Lee , Cian Murphy , Katherine Belessiotis , Nikolaos Diamantis , Uma Mukherjee , Fanny Pommeret , Annabelle Stoclin , Clara Martinez-Vila , Riccardo Bruna , Gianluca Gaidano , Francesca D'Avanzo , Alessandra Gennari , Janhavi Athale , Peter Eichacker , David J. Pinato , Parizad Torabi-Parizi , Alessio Cortellini INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES（2024）
Key words
COVID-19, SARS-CoV-2, Malignancy, Immunotherapy, Checkpoint inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
